167 related articles for article (PubMed ID: 36312851)
21. Immunodeficiency in Pancreatic Adenocarcinoma with Diabetes Revealed by Comparative Genomics.
Yan Y; Gao R; Trinh TLP; Grant MB
Clin Cancer Res; 2017 Oct; 23(20):6363-6373. PubMed ID: 28684632
[No Abstract] [Full Text] [Related]
22. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.
Zhang X; Wang Y; A G; Qu C; Chen J
Front Immunol; 2021; 12():721030. PubMed ID: 34531868
[TBL] [Abstract][Full Text] [Related]
23. Association of aging-related genes with prognosis and immune infiltration in pancreatic adenocarcinoma.
Xue S; Ge W; Wang K; Mao T; Zhang X; Xu H; Wang Y; Yao J; Li S; Yue M; Ma J; Wang Y; Shentu D; Cui J; Wang L
Front Cell Dev Biol; 2022; 10():942225. PubMed ID: 36003146
[TBL] [Abstract][Full Text] [Related]
24. Four drug metabolism-related subgroups of pancreatic adenocarcinoma in prognosis, immune infiltration, and gene mutation.
Zhang T; Zhu L; Cai J; He J
Open Med (Wars); 2022; 17(1):427-440. PubMed ID: 35340619
[TBL] [Abstract][Full Text] [Related]
25. Identify potential prognostic indicators and tumor-infiltrating immune cells in pancreatic adenocarcinoma.
Shi T; Gao G
Biosci Rep; 2022 Feb; 42(2):. PubMed ID: 35083488
[TBL] [Abstract][Full Text] [Related]
26. Mutations in
Liu D; Benzaquen J; Morris LGT; Ilié M; Hofman P
Cancers (Basel); 2022 Jun; 14(11):. PubMed ID: 35681795
[TBL] [Abstract][Full Text] [Related]
27. Identification of the Real Hub Gene and Construction of a Novel Prognostic Signature for Pancreatic Adenocarcinoma Based on the Weighted Gene Co-expression Network Analysis and Least Absolute Shrinkage and Selection Operator Algorithms.
Yuan Q; Ren J; Wang Z; Ji L; Deng D; Shang D
Front Genet; 2021; 12():692953. PubMed ID: 34490033
[No Abstract] [Full Text] [Related]
28. Integrating Genetic and Transcriptomic Data to Reveal Pathogenesis and Prognostic Markers of Pancreatic Adenocarcinoma.
Bai K; Zhao T; Li Y; Li X; Zhang Z; Du Z; Wang Z; Xu Y; Sun B; Bai X
Front Genet; 2021; 12():747270. PubMed ID: 34567094
[TBL] [Abstract][Full Text] [Related]
29. Mutation of MUC16 Is Associated With Tumor Mutational Burden and Lymph Node Metastasis in Patients With Gastric Cancer.
Zhang F; Li X; Chen H; Guo J; Xiong Z; Yin S; Jin L; Chen X; Luo D; Tang H; Mao C; Lian L
Front Med (Lausanne); 2022; 9():836892. PubMed ID: 35211490
[TBL] [Abstract][Full Text] [Related]
30. The expression profile of Gasdermin C-related genes predicts the prognosis and immunotherapy response of pancreatic adenocarcinoma.
Xia XH; Yin WJ; Mao JF; Liu P; Qin CD; Hu JJ; Liu SY; Wang CM; Zou DH; Yang HJ; Yu Y; Huang J
Am J Cancer Res; 2023; 13(4):1240-1258. PubMed ID: 37168356
[TBL] [Abstract][Full Text] [Related]
31. Comprehensive characterization of extracellular matrix-related genes in PAAD identified a novel prognostic panel related to clinical outcomes and immune microenvironment: A silico analysis with
Chen X; Yuan Q; Liu J; Xia S; Shi X; Su Y; Wang Z; Li S; Shang D
Front Immunol; 2022; 13():985911. PubMed ID: 36311789
[TBL] [Abstract][Full Text] [Related]
32. A panel of necroptosis-related genes predicts the prognosis of pancreatic adenocarcinoma.
Luo Z; Wang L; Shang Z; Guo Q; Liu Q; Zhang M; Li T; Wang Y; Zhang Y; Zhang Y; Zhang X
Transl Oncol; 2022 Aug; 22():101462. PubMed ID: 35635957
[TBL] [Abstract][Full Text] [Related]
33. Increased expression of zinc transporter ZIP4, ZIP11, ZnT1, and ZnT6 predicts poor prognosis in pancreatic cancer.
Zhu B; Huo R; Zhi Q; Zhan M; Chen X; Hua ZC
J Trace Elem Med Biol; 2021 May; 65():126734. PubMed ID: 33631610
[TBL] [Abstract][Full Text] [Related]
34. Expression pattern and prognostic value of circadian clock genes in pancreatic adenocarcinoma.
Zhang LL; He QK; Lv YN; Zhang ZJ; Xiang YK
Chronobiol Int; 2021 May; 38(5):681-693. PubMed ID: 33691542
[TBL] [Abstract][Full Text] [Related]
35. Integrate analysis of the promote function of Cell division cycle-associated protein family to pancreatic adenocarcinoma.
Xing C; Wang Z; Zhu Y; Zhang C; Liu M; Hu X; Chen W; Du Y
Int J Med Sci; 2021; 18(3):672-684. PubMed ID: 33437202
[No Abstract] [Full Text] [Related]
36. Bioinformatics analysis identified MMP14 and COL12A1 as immune-related biomarkers associated with pancreatic adenocarcinoma prognosis.
Li Y; Su Z; Wei B; Qin M; Liang Z
Math Biosci Eng; 2021 Jun; 18(5):5921-5942. PubMed ID: 34517516
[TBL] [Abstract][Full Text] [Related]
37. BDNF Acts as a Prognostic Factor Associated with Tumor-Infiltrating Th2 Cells in Pancreatic Adenocarcinoma.
Zhu Y; Zhang C; Zhao D; Li W; Zhao Z; Yao S; Zhao D
Dis Markers; 2021; 2021():7842035. PubMed ID: 34777634
[TBL] [Abstract][Full Text] [Related]
38. The cancer driver genes IDH1/2, JARID1C/ KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism.
Chang S; Yim S; Park H
Exp Mol Med; 2019 Jun; 51(6):1-17. PubMed ID: 31221981
[TBL] [Abstract][Full Text] [Related]
39. CXCL10 is a Tumor Microenvironment and Immune Infiltration Related Prognostic Biomarker in Pancreatic Adenocarcinoma.
Huang H; Zhou W; Chen R; Xiang B; Zhou S; Lan L
Front Mol Biosci; 2021; 8():611508. PubMed ID: 33681290
[TBL] [Abstract][Full Text] [Related]
40. Construction of an RNA-Binding Protein-Related Prognostic Model for Pancreatic Adenocarcinoma Based on TCGA and GTEx Databases.
Wen X; Shao Z; Chen S; Wang W; Wang Y; Jiang J; Ma Q; Zhang L
Front Genet; 2020; 11():610350. PubMed ID: 33584809
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]